In Russian and USSR literature, it is called Shereshevsky–Turner syndrome to acknowledge that the condition was first described as hereditary in 1925 by the Soviet endocrinologist Nikolai Shereshevsky, who believed that it was due to the underdevelopment of the gonads and the anterior pituitary gland and was combined with congenital malformations of internal development.The first published report of a female with a 45,X karyotype was in 1959 by Charles Ford and colleagues in Harwell near Oxford, and Guys Hospital in London. It was found in a 14-year-old girl with signs of Turner syndrome. See also
Other human sex chromosome aneuploids:
XYY syndrome,
Klinefelter syndrome (XXY),
Triple X syndrome,
Noonan syndrome, a disorder which is often confused with Turner syndrome because of several physical features that they have in common. Creeping vole, a mammal species in which it is typical for females to have only one X chromosome. Notes
References
Further reading
External links

Turner Syndrome at the National Institute of Child Health and Human Development
Turner Syndrome at NIHs Office of Rare Diseases
Endocrine and Metabolic Diseases Information Service
Prenatal testing also is available to determine whether the fetus will have the disease or is a carrier. Treatment
There are no specific treatments for lipid storage disorders; however, there are some highly effective enzyme replacement therapies for people with type 1 Gaucher disease and some patients with type 3 Gaucher disease. There are other treatments such as the prescription of certain drugs such as phenytoin and carbamazepine to treat pain for patients with Fabry disease. Furthermore, gene therapies and bone marrow transplantation may prove to be effective for certain lipid storage disorders.Diet restrictions do not help prevent the buildup of lipids in the tissues. See also
Xanthomatosis
Niemann–Pick disease

References


== External links ==